Mesenchyme Forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancers
about
Novel insights into the bovine polled phenotype and horn ontogenesis in BovidaeThe variant rs1867277 in FOXE1 gene confers thyroid cancer susceptibility through the recruitment of USF1/USF2 transcription factorsNEDD9 is a positive regulator of epithelial-mesenchymal transition and promotes invasion in aggressive breast cancerLoss of FOXA1/2 is essential for the epithelial-to-mesenchymal transition in pancreatic cancerTranscription elongation regulator 1 is a co-integrator of the cell fate determination factor Dachshund homolog 1Engagement of I-branching {beta}-1, 6-N-acetylglucosaminyltransferase 2 in breast cancer metastasis and TGF-{beta} signalingSET8 promotes epithelial-mesenchymal transition and confers TWIST dual transcriptional activitiesFOXC2 controls formation and maturation of lymphatic collecting vessels through cooperation with NFATc1Mesenchymal-epithelial transition in epithelial response to injury: the role of Foxc2The Foxc2 transcription factor regulates tumor angiogenesisThe epithelial-mesenchymal transition generates cells with properties of stem cellsThe basics of epithelial-mesenchymal transitionFoxc2 transcription factor: a newly described regulator of angiogenesisMechanisms of TGFβ-Induced Epithelial-Mesenchymal TransitionStem cell technology in breast cancer: current status and potential applicationsThe Therapeutic Targets of miRNA in Hepatic Cancer Stem CellsEpithelial-Mesenchymal Transition (EMT) and Regulation of EMT Factors by Steroid Nuclear Receptors in Breast Cancer: A Review and in Silico InvestigationThe network of pluripotency, epithelial-mesenchymal transition, and prognosis of breast cancerCirculating Tumor Cells: A Window Into Tumor Development and Therapeutic EffectivenessAn oncologist׳s friend: How Xenopus contributes to cancer researchBreast cancer epithelial-to-mesenchymal transition: examining the functional consequences of plasticityTranscriptional control of cancer metastasisRegulation of mesenchymal phenotype by MicroRNAs in cancerMolecular mechanisms of epithelial-mesenchymal transitionMicroRNAs in colorectal cancer: role in metastasis and clinical perspectivesPost-transcriptional Control of Tumor Cell Autonomous Metastatic Potential by CCR4-NOT Deadenylase CNOT7An EMT-driven alternative splicing program occurs in human breast cancer and modulates cellular phenotypeTackling Cancer Stem Cells via Inhibition of EMT Transcription FactorsRole of TGFβ in regulation of the tumor microenvironment and drug delivery (review)TGFβ Signaling in Tumor Initiation, Epithelial-to-Mesenchymal Transition, and MetastasisThe role of splicing factors in deregulation of alternative splicing during oncogenesis and tumor progressionEpithelial-to-mesenchymal transition in breast cancer: a role for insulin-like growth factor I and insulin-like growth factor-binding protein 3?The emerging roles of forkhead box (Fox) proteins in cancerHuman embryonic stem cells and metastatic colorectal cancer cells shared the common endogenous human microRNA-26bCancer stem cells in solid tumours: accumulating evidence and unresolved questionsTwist: a molecular target in cancer therapeuticsSustained proliferation in cancer: Mechanisms and novel therapeutic targetsThe Foxc2 transcription factor regulates angiogenesis via induction of integrin beta3 expressionFOXC1 contributes to microvascular invasion in primary hepatocellular carcinoma via regulating epithelial-mesenchymal transitionResidual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
P2860
Q21090752-3B593633-A228-4131-A330-2E9213C4CE61Q21092455-FBA468EB-CB4D-4190-A7F1-589166321A94Q21560948-DE9F444F-B9C9-406B-9A51-6C98CFED62C7Q24299591-007D692D-75E5-4EA8-BCCF-B4EDD1382726Q24303837-3ECADD38-7103-4AC4-99A0-D1B5BAEC623BQ24313363-FD69C94C-EDD0-4B7A-B39E-9FF15FA2E356Q24339520-6ACFEABC-3840-4C2A-A6B0-468C0241705FQ24641842-38099D1E-523D-4EA9-B571-FE4E3626F8F2Q24645523-430AE747-298D-47EA-9587-695F43E927B3Q24647592-A1C3E805-0442-4FC2-9972-4CDF36D20444Q24650786-87C5196E-F74D-4B65-B372-ACFA3B4619A5Q24652992-D6EB377C-3F28-4FBF-AEB7-0FDE1DEBCE17Q24653645-D14A8A93-74C9-46B9-9EE7-E949D36E9583Q26745545-CD1C1C8E-4A95-4AE3-8118-1E79082215FEQ26746223-D0C19FA7-DB87-45F5-822F-FB60EE4712B9Q26749450-0F0056A0-CCC6-4C67-8CF7-2E5CE4F93296Q26770051-B8336EE3-5642-4398-A5C8-C1291F3DD8E2Q26785448-A66E250B-7CC2-43DC-BACA-115165D961ACQ26827815-B129279F-946E-473E-8186-DA86972E1850Q26849774-2A5A3431-6950-4950-B069-90B42F5C907BQ26851620-6B6014F3-CDD8-421F-9C92-336D8CA60702Q26992024-D8292182-326B-4034-8E6C-2D939BBEACB4Q27009506-BAF9DC0B-21F7-4D57-B191-4307739974BFQ27013743-455D23ED-2B3F-4A2B-A30B-8E09B8377763Q27022292-65B8741B-680A-457D-BA3D-A556A0AC1773Q27309177-F1585A74-11A5-4AD0-9811-69973A16B8E6Q27339197-D9A12D1B-A4EA-413B-BBAD-A3822FA06694Q28079863-783EF3CC-534E-4139-914B-1F88D679D407Q28081170-846A1BC1-0454-43D0-BDC7-E2C1C582C3B2Q28083107-64516F1C-19F7-4EA7-A591-91CA0F8C2C60Q28083838-81810355-6176-45E2-9832-491BBFB27DC7Q28087055-CDBFA6BD-1B24-42CF-863F-54C63E71AD45Q28253741-C6A7EC51-E243-436A-8A11-9FC2800CC5E1Q28292904-3706B929-B8C9-46EB-9CC9-48630177A561Q28293535-92E0D092-0E33-442C-B59E-5CC777A2AE7DQ28294941-515C6515-62A0-4EA9-92F5-BE0EE1079D67Q28396388-3A19038F-92A8-490C-B050-D89BB26BF849Q28591594-0CB7788F-C342-4336-9AE0-E34B29796D9AQ28910325-A1023838-CFAB-4D52-8AEC-13F449718268Q29620020-FA432831-BADB-4A15-AFFE-232E97D42398
P2860
Mesenchyme Forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancers
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Mesenchyme Forkhead 1 (FOXC2) ...... sive basal-like breast cancers
@ast
Mesenchyme Forkhead 1 (FOXC2) ...... sive basal-like breast cancers
@en
Mesenchyme Forkhead 1 (FOXC2) ...... sive basal-like breast cancers
@nl
type
label
Mesenchyme Forkhead 1 (FOXC2) ...... sive basal-like breast cancers
@ast
Mesenchyme Forkhead 1 (FOXC2) ...... sive basal-like breast cancers
@en
Mesenchyme Forkhead 1 (FOXC2) ...... sive basal-like breast cancers
@nl
prefLabel
Mesenchyme Forkhead 1 (FOXC2) ...... sive basal-like breast cancers
@ast
Mesenchyme Forkhead 1 (FOXC2) ...... sive basal-like breast cancers
@en
Mesenchyme Forkhead 1 (FOXC2) ...... sive basal-like breast cancers
@nl
P2093
P2860
P3181
P356
P1476
Mesenchyme Forkhead 1 (FOXC2) ...... sive basal-like breast cancers
@en
P2093
Alicia Zhou
Andrea L Richardson
Gunda Schwaninger
Jeffery L Kutok
Kimberly Hartwell
Mary Brooks
Naoyuki Miura
P2860
P304
P3181
P356
10.1073/PNAS.0703900104
P407
P577
2007-06-12T00:00:00Z